Has Faiza Haque received payments from drug or device companies?

Yes. Drug and device makers reported $2,942 in general payments to Faiza Haque across 111 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Faiza Haque did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Faiza Haque come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Faiza Haque

Psychiatric/Mental Health · Pearland, TXNPI 1982249728

Payments from drug & device makers

$2,942in general payments, 2019–2025

Across 111 payments — averaging $26.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$501
Corium, LLC$460
Johnson & Johnson$439
Neurocrine Biosciences, Inc.$251
Teva Pharmaceuticals USA, Inc.$247
Otsuka America Pharmaceutical, Inc.$188
plus $857 from 12 others

What the payments were for

Food & beverage$2,82596%
Education$1164%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	27	$501
Corium, LLC	16	$460
Johnson & Johnson	14	$439
Neurocrine Biosciences, Inc.	5	$251
Teva Pharmaceuticals USA, Inc.	5	$247
Otsuka America Pharmaceutical, Inc.	4	$188
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$172
Alkermes, Inc.	3	$159
Sunovion Pharmaceuticals Inc.	11	$137
Axsome Therapeutics, Inc.	5	$122
Neos Therapeutics, LP	4	$65
Indivior Inc.	3	$64
Lundbeck LLC	2	$37
E.r. Squibb & Sons, L.L.C.	1	$28
Ironshore Pharmaceuticals Inc.	1	$23
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
Supernus Pharmaceuticals, Inc.	1	$16
Vanda Pharmaceuticals Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,942 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	12	$1,068
Olanzapine	51	$777
Divalproex Sodium ErDivalproex Sodium	20	$475
Trazodone Hcl	14	$316
Lamotrigine	24	$198
Lorazepam	40	$197
Paroxetine Hcl	29	$149
Alprazolam	15	$124
Buspirone Hcl	20	$80
Fluoxetine Hcl	13	$55
Zolpidem Tartrate	18	$21

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Pearland

Tracy HicksLongview$684K
Natalie TellezHouston$602K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Victor IlogEl Paso$167K
Lisa ShamblinGrapevine$163K
Monique GonzalezSan Antonio$126K
Marguerite AddisonWaco$118K
Komi Kokou-AbiRound Rock$88K
Jaime Nelson DensonAustin$88K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →